TuHURA Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HURA and other ETFs, options, and stocks.

About HURA

TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. The firm’s lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. 

CEO
James A. Bianco
CEOJames A. Bianco
Employees
19
Employees19
Headquarters
Tampa, Florida
HeadquartersTampa, Florida
Founded
2023
Founded2023
Employees
19
Employees19

HURA Key Statistics

Market cap
171.66M
Market cap171.66M
Price-Earnings ratio
-0.05
Price-Earnings ratio-0.05
Dividend yield
Dividend yield
Average volume
133.16K
Average volume133.16K
High today
$4.02
High today$4.02
Low today
$3.80
Low today$3.80
Open price
$3.95
Open price$3.95
Volume
23.96K
Volume23.96K
52 Week high
$14.60
52 Week high$14.60
52 Week low
$1.80
52 Week low$1.80

People also own

Based on the portfolios of people who own HURA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.